BOEHRINGER INGELHEIM VENTURE FUND
Boehringer Ingelheim Venture Fund GmbH (BIVF) invests in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research. BIVF is searching for significant enhancements in patient care through pioneering science and its clinical translation by building long-term relationships with scientists and entrepreneurs. BIVF’s focus is to target unprecedented therapeutic concepts addressing high medical needs in immuno-oncology, regenerative medicine, infectious diseases and digital health. These may include novel platform technologies to address so far undruggable targets, new generation vaccines and/or new biological entities, such as oncolytic virotherapy.
BOEHRINGER INGELHEIM VENTURE FUND
Industry:
Biotechnology Finance Venture Capital
Founded:
2010-01-01
Status:
Active
Contact:
+49 6132 77 90780
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Apache ReCAPTCHA New Relic GlobalSign GlobalSign Domain Verification
Similar Organizations
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Headline
Headline is a global venture capital firm investing in winning teams across stages and geographies.
Novartis Venture Fund
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-01 | C-mo Medical Solutions | Boehringer Ingelheim Venture Fund investment in Seed Round - C-mo Medical Solutions | 4.1 M EUR |
| 2022-06-13 | ImCheck Therapeutics | Boehringer Ingelheim Venture Fund investment in Series C - ImCheck Therapeutics | 96 M EUR |
| 2022-03-03 | ArrePath | Boehringer Ingelheim Venture Fund investment in Seed Round - ArrePath | 20 M USD |
| 2022-02-16 | Centauri Therapeutics | Boehringer Ingelheim Venture Fund investment in Series A - Centauri Therapeutics | 24 M GBP |
| 2021-12-16 | Brainomix | Boehringer Ingelheim Venture Fund investment in Series B - Brainomix | 16 M GBP |
| 2021-12-09 | OncoMyx Therapeutics | Boehringer Ingelheim Venture Fund investment in Series B - OncoMyx Therapeutics | 50 M USD |
| 2021-12-08 | Viron Inc. | Boehringer Ingelheim Venture Fund investment in Series B - Viron Inc. | 50 M USD |
| 2021-11-09 | Asgard Therapeutics | Boehringer Ingelheim Venture Fund investment in Seed Round - Asgard Therapeutics | 6 M EUR |
| 2021-10-28 | Optina Diagnostics | Boehringer Ingelheim Venture Fund investment in Series A - Optina Diagnostics | 24.8 M CAD |
| 2021-10-14 | Abalos Therapeutics | Boehringer Ingelheim Venture Fund investment in Series A - Abalos Therapeutics | 31 M EUR |